Scout Bio is based in Philadelphia. It has raised $20M in total funding. Latest round: Series A.
Scout Bio funding overview
Scout Bio is based in Philadelphia. Scout Bio has raised $20M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Scout Bio runs through 2023; nothing later has been disclosed. Investors on record include Digitalis Ventures, RiverVest Venture Partners, GreenSpring Associates, Frazier Healthcare Partners, Adage Capital Management, Correlation Ventures. 6 distinct backers are named across the disclosed rounds.
Scout Bio has raised $20M in total disclosed funding across the rounds on record.
Who has invested in Scout Bio?
Digitalis Ventures, RiverVest Venture Partners, GreenSpring Associates, Frazier Healthcare Partners, Adage Capital Management, Correlation Ventures are named among the investors backing Scout Bio.
What was the latest Scout Bio funding round?
The most recent disclosed round is a Series A, announced in January 2023.
Where is Scout Bio based?
Scout Bio is based in Philadelphia.
When did Scout Bio last raise?
The last disclosed Scout Bio round closed in January 2023 at Series A.
We update the Scout Bio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Philadelphia and their backers are listed below.
